Hercules Capital, Inc. Stock: price and management transactions · United States · SEC (Form 4)Follow the Hercules Capital, Inc. share price and the full insider trade history of the company, a listed issuer based in United States. Shares are listed on the US market, under the authority of SEC (Form 4). Operating in the Finance & Banking sector, Hercules Capital, Inc. has published 305 insider filings. Market capitalisation: €3bn. The latest transaction was filed on 13 July 2026 (Retenue fiscale). Among the most active insiders: Bluestein Scott. Every trade is free.
Analyst consensus: bullish or bearish? Analysts rate Hercules Capital, Inc. Buy (bullish), based on 8 analysts. Average price target: US$19.03.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 10,586 of 29,062 companies
FCF yld -13%
Earn yld 9.2%
EV/EBITDA 11.5x
ROE 17%
Gross mgn ·
Net mgn 66%
Debt/EBITDA 4.9x
Pillars 2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 13 July 2026
All Executives305 Thresholds0 Prospectus0 Other0
Declarations 305 total
● Chief Executive Officer · Executives · 9 Jul 2026
9,741 shares @ US$15.69 0.0051% mcap 0.2% of flow Common Stock SEC:0001505910-26-000008:0
● Chief Executive Officer · Executives · 9 Jul 2026
10,652 shares @ US$15.69 0.0056% mcap 0.3% of flow Common Stock SEC:0001505910-26-000008:1
● Chief Legal Officer & CCO · Executives · 9 Jul 2026
956 shares @ US$15.69 0.0005% mcap 0.7% of flow Common Stock SEC:0001902313-26-000006:0
● Chief Legal Officer & CCO · Executives · 9 Jul 2026
1,018 shares @ US$15.69 0.0005% mcap 0.8% of flow Common Stock SEC:0001902313-26-000006:1
● Chief Operating Officer · Executives · 9 Jul 2026
1,433 shares @ US$15.69 0.0008% mcap 0.9% of flow Common Stock SEC:0001907321-26-000007:0
● Chief Operating Officer · Executives · 9 Jul 2026
1,365 shares @ US$15.69 0.0007% mcap 0.8% of flow Common Stock SEC:0001907321-26-000007:1
● President · Executives · 9 Jul 2026
3,011 shares @ US$15.69 0.0016% mcap 0.5% of flow Common Stock SEC:0001768773-26-000009:0
● President · Executives · 9 Jul 2026
3,458 shares @ US$15.69 0.0018% mcap 0.6% of flow Common Stock SEC:0001768773-26-000009:1
◆ Director · Executives · 18 Jun 2026
3,873 shares Common Stock SEC:0001207407-26-000009:0
◆ Director · Executives · 18 Jun 2026
3,873 shares Common Stock SEC:0001207407-26-000010:0
◆ Director · Executives · 18 Jun 2026
3,873 shares Common Stock SEC:0001207407-26-000011:0
◆ Director · Executives · 18 Jun 2026
3,873 shares Common Stock SEC:0001207407-26-000008:0
● Chief Executive Officer · Executives · 9 Apr 2026
10,652 shares @ US$14.74 0.2% of flow Common Stock SEC:0001505910-26-000005:0
● Chief Executive Officer · Executives · 9 Apr 2026
9,741 shares @ US$14.74 0.2% of flow Common Stock SEC:0001505910-26-000005:1
● Chief Legal Officer & CCO · Executives · 9 Apr 2026
956 shares @ US$14.74 1.0% of flow Common Stock SEC:0001902313-26-000004:0
● Chief Legal Officer & CCO · Executives · 9 Apr 2026
1,018 shares @ US$14.74 1.0% of flow Common Stock SEC:0001902313-26-000004:1
● Chief Operating Officer · Executives · 9 Apr 2026
1,365 shares @ US$14.74 1.3% of flow Common Stock SEC:0001907321-26-000005:0
● Chief Operating Officer · Executives · 9 Apr 2026
1,433 shares @ US$14.74 1.4% of flow Common Stock SEC:0001907321-26-000005:1
● Chief Financial Officer · Executives · 9 Apr 2026
3,458 shares @ US$14.74 0.6% of flow Common Stock SEC:0001768773-26-000006:0
● Chief Financial Officer · Executives · 9 Apr 2026
3,011 shares @ US$14.74 0.5% of flow Common Stock SEC:0001768773-26-000006:1
▲ Director · Executives · 26 Mar 2026
7,317 shares @ US$14.35 20.7% of flow Common Stock SEC:0001934428-26-000001:0
Canonical exit: 24 Jun 2026 (T+90) ▲ Director · Executives · 26 Mar 2026
7,317 shares @ US$14.35 17.7% of flow Common Stock SEC:0001668279-26-000002:0
Canonical exit: 24 Jun 2026 (T+90) ▲ Director · Executives · 26 Mar 2026
7,317 shares @ US$14.35 32.3% of flow Common Stock SEC:0001605860-26-000003:0
Canonical exit: 24 Jun 2026 (T+90) ▲ Director · Executives · 26 Mar 2026
7,300 shares @ US$14.30 15.5% of flow Common Stock SEC:0001399121-26-000004:0
Canonical exit: 24 Jun 2026 (T+90) ▲ Director · Executives · 26 Mar 2026
2,926 shares @ US$14.35 13.7% of flow Common Stock SEC:0001335754-26-000002:0
Canonical exit: 24 Jun 2026 (T+90) 25 of 305 declarations
Load more (280 remaining) 关于 Hercules Capital, Inc. Hercules Capital, Inc. (NYSE: HTGC) 是一家总部位于美国加利福尼亚州圣马特奥的美国专业金融公司。对于讲法语的投资者来说,它最好被理解为一家专注于风险贷款的领先商业发展公司 (BDC):为创新型、风险资本支持的公司提供债务资本。Hercules 将自己描述为专注于这一利基市场的最大和领先的专业金融公司,以及创新企业家及其风险资本赞助商的首选贷款机构。([htgc.com](https://www.htgc.com/about/?utm_source=openai))
公司的核心业务是为高创新行业,特别是技术和生命科学领域的公司提供高级担保贷款和增长融资。其融资解决方案通常支持增长资本需求、扩张、产品开发、营运资金和其他战略性公司举措。实际上,Hercules 提供了一种替代传统商业银行贷款的方式,其量身定制且灵活的结构专为可能对传统贷款机构来说过早、过于专业或过于注重增长的公司设计。([htgc.com](https://www.htgc.com/about/?utm_source=openai))
Hercule Capital 的商业模式与风险生态系统紧密相连。它通过服务处于不同阶段的风险投资支持的企业建立了其特许经营权,从早期成长型公司到仍需要非稀释性资本的更成熟发行人。该公司的总部位于加利福尼亚州圣马特奥,其运营范围主要以美国为中心,尽管其客户群可能包括具有更广泛国内或国际抱负的公司,具体取决于其融资需求。([htgc.com](https://www.htgc.com/contact-us/?utm_source=openai))
从竞争角度来看,Hercules 受益于深厚的行业专业化、与风险投资公司的强大关系以及在信贷市场相对利基领域中长期建立的声誉。这种专业化很重要:技术和生命科学借款人通常需要比银行债务更灵活但比股权稀释性更小的融资。Hercules 定位填补这一空白,这支持了其市场相关性,并使其能够获得与更普遍的贷款机构不同的交易流。([htgc.com](https://www.htgc.com/about/?utm_source=openai))
最近的发展仍然支持投资案例。在2025年5月和2026年5月,Hercules 报告的季度业绩突出了强劲的发行量和季度末超过1.0 billion美元的流动性水平。该公司还在2026年第一季度披露了创纪录的新债务和股权承诺,表明对其资本的需求依然强劲。对于关注 SEC Form 4 内部交易的投资者来说,HTGC 因此是一个值得关注的名称,既可以关注其信贷表现,也可以通过内部活动关注管理层的信心信号。([businesswire.com](https://www.businesswire.com/news/home/20250501258025/en/Hercules-Capital-Reports-First-Quarter-2025-Financial-Results?utm_source=openai))